GL1X · GenesisL1 explorer

MolNFT v1 · #137970 · protein

Solution structure of C2 domain from protein kinase C alpha in ternary complex with calcium and V5-phm peptide

5W4S · Protein kinase C alpha type: “Solution structure of C2 domain from protein kinase C alpha in ternary complex with calcium and V5-phm peptide”. Solution nmr, 3 ligands (ACE, CA, NH2), 1 pocket (best druggability 0.30). MolNFT v1…

PDB
5W4S
Type
protein
Length
149 residues
Chains
2
Method
solution nmr
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Protein kinase C alpha type; V5-phm peptide
EC
2.7.11.13
UniProt
P05696
Ligands
ACE, CA, NH2
Pockets
1 · best druggability 0.30

Structure

solution nmr · 2 distinct chains · 10% helix, 44% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AProtein kinase C alpha type (EC 2.7.11.13)protein13911% helix, 47% strandP05696
BV5-phm peptideprotein100% helix, 0% strand—

Ligands and binding sites

  • ACE · Acetyl group · ligand · chains A, B
  • CA · Calcium ion · metal · 2 copies · chains A
  • NH2 · Amino group · ion · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1560.300.7613empty

Interfaces

1 interface between chains.

  • A–B · 613 Ų buried · 12 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 1 covalent, 1 modified (covalent ligand, phosphorylation).

Compared structures

  • 5W4S · Solution structure of C2 domain from protein kinase C alpha in ternary complex with… · the same entry in another collection · chain A against A, TM-score 1.00
  • P05696 · AlphaFold monomer V2.0 prediction for protein kinase C alpha type (P05696) · a predicted model of the same protein · chain A against A, TM-score 0.88

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.